US2021023102A1PendingUtilityA1

Compositions for use in improving stool consistency or frequency in infants or young children

63
Assignee: NESTLE SAPriority: Mar 5, 2015Filed: Sep 28, 2020Published: Jan 28, 2021
Est. expiryMar 5, 2035(~8.6 yrs left)· nominal 20-yr term from priority
A61P 1/06A23L 33/21A23L 33/135A61K 9/0056A61P 1/00A61K 2035/115A23V 2002/00A23L 33/40A61K 35/741A61K 31/702A23L 33/125A23L 33/10A23V 2400/21A23V 2400/11A23V 2400/51
63
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to a nutritional composition comprising at least one fucosylated oligosaccharide for use in preventing and/or treating constipation and/or in improving stool consistency/frequency in an infant or a young child.

Claims

exact text as granted — not AI-modified
1 . (canceled) 
     
     
         2 . A method of treating colics in an infant or a young child in need thereof, the method comprising administering a nutritional composition to the infant or young child, the nutritional composition comprising at least one fucosylated oligosaccharide, and wherein the fucosylated oligosaccharide(s) is/are in a total amount of 0.8-1.5 g/L of the composition and/or in a total amount of 0.55-1.05 g/100 g of composition on a dry weight basis. 
     
     
         3 . The method according to  claim 2  wherein the fucosylated oligosaccharide is selected from the group consisting of 2′-fucosyllactose, 3′ fucosyllactose, difucosyllactose, lacto-N-fucopentaose I, lacto-N-fucopentaose II, lacto-N-fucopentaose III, lacto-N-fucopentaose V, lacto-N-fucohexaose, lacto-N-difucohexaose I, fucosyllacto-N-hexaose, fucosyllacto-N-neohexaose I, fucosyllacto-N-neohexaose II, difucosyllacto-N-hexaose I, difucosyllacto-N-neohexaose I, difucosyllacto-N-neohexaose II, fucosyl-para-Lacto-N-hexaose, and any combination thereof. 
     
     
         4 . The method according to  claim 2 , wherein the fucosylated oligosaccharide comprises a 2′ fucosyl-epitope. 
     
     
         5 . The method according to  claim 2 , wherein the fucosylated oligosaccharide is 2′-fucosyllactose (2′FL). 
     
     
         6 . The method according to  claim 2 , wherein the fucosylated oligosaccharide(s) is/are in a total amount of 0.2-3 g/L of the composition and/or in a total amount of 0.13-2.1 g/100 g of composition on a dry weight basis. 
     
     
         7 . The method according to  claim 2 , wherein the fucosylated oligosaccharide(s) is/are in a total amount of 0.8-1.5 g/L of the composition and/or in a total amount of 0.55-1.05 g/100 g of composition on a dry weight basis. 
     
     
         8 . The method according to  claim 2 , wherein the fucosylated oligosaccharide(s) is/are in a total amount of 1-1.25 g/L of the composition and/or in a total amount of 0.69-0.87 g/100 g of composition on a dry weight basis. 
     
     
         9 . (canceled) 
     
     
         10 . The method according to  claim 2 , wherein the composition further comprising at least one probiotic microorganism. 
     
     
         11 - 13 . (canceled) 
     
     
         14 . The method according to  claim 2 , wherein the nutritional composition is in a form selected from the group consisting of an infant formula, a starter infant formula, a follow-on or follow-up infant formula, a baby food, an infant cereal composition, a fortifier and a supplement. 
     
     
         15 . (canceled) 
     
     
         16 . The method according to  claim 2 , wherein the composition does not comprise any N-acetylated oligosaccharides. 
     
     
         17 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.